Santhera Pharmaceuticals Holding AG (0QN1)
LSE
Closed
Oct 14, 2026
Day's Range
13.4852 wk Range
9.50Overview - 0QN1 - Santhera Pharmaceuticals Holding AG
Key Statistics
Valuation
Enterprise Value
227.68M
EV / EBITDA
‪-6.99‬
Profitability
Profit Margin
‪-63.79%‬
Operating Margin
‪-4.07%‬
Return on Assets
‪-15.64%‬
Return on Equity
‪-620.02%‬
Ownership
Shares Outstanding
6.43M
Float
11.28M
Held by Insiders
‪14.50%‬
Held by Institutions
‪14.24%‬
Price stats
Beta
‪-0.27‬
50-Day Avg
‪9.91‬
200-Day Avg
‪8.98‬
Market Cap - 0QN1 - Santhera Pharmaceuticals Holding AG
Peers - 0QN1 - Santhera Pharmaceuticals Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0QN1LSESanthera Pharmaceuticals Holding AG99.36MMarket Cap+32.61%52-week change—P/E (Trailing)‪-63.79%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock130.30BMarket Cap+18.90%52-week change53.88P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.107.69BMarket Cap+88.04%52-week change84.05P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.81.30BMarket Cap+23.54%52-week change10.70P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE43.34BMarket Cap+6.62%52-week change34.95P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0QN1 - Santhera Pharmaceuticals Holding AG
About
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating diseases. The company primarily targets unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
